Last reviewed · How we verify

catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel

AIO-Studien-gGmbH · Phase 2 active Small molecule

catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel is a Small molecule drug developed by AIO-Studien-gGmbH. It is currently in Phase 2 development. Also known as: Catumaxomab + FLOT.

At a glance

Generic namecatumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel
Also known asCatumaxomab + FLOT
SponsorAIO-Studien-gGmbH
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel

What is catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel?

catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel is a Small molecule drug developed by AIO-Studien-gGmbH.

Who makes catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel?

catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel is developed by AIO-Studien-gGmbH (see full AIO-Studien-gGmbH pipeline at /company/aio-studien-ggmbh).

Is catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel also known as anything else?

catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel is also known as Catumaxomab + FLOT.

What development phase is catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel in?

catumaxomab, Fluorouracil, leucovorin, oxaliplatin, docetaxel is in Phase 2.

Related